Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany

Drug budget and prescription control measures are implemented regionally in Germany, meaning that the uptake of pharmaceuticals, including biosimilars, can vary by region. We examine regional market dynamics of tumor necrosis factor alpha (TNFα) inhibitor originators and biosimilars in Germany and s...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Evelien Moorkens, Teresa Barcina Lacosta, Arnold G. Vulto, Martin Schulz, Gabriele Gradl, Salka Enners, Gisbert Selke, Isabelle Huys, Steven Simoens
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: MDPI AG 2020-10-01
Reeks:Pharmaceuticals
Onderwerpen:
infliximab
etanercept
TNFα inhibitors
biologics
biosimilars
Germany
Online toegang:https://www.mdpi.com/1424-8247/13/10/324
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items